Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin T Among

Nicklaus P Ashburn1,2, Anna C Snavely1,3, James C O'Neill1

  • 1Department of Emergency Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina.

JAMA Cardiology
|March 1, 2023
PubMed

Insights

The European Society of Cardiology (ESC) 0/1-hour algorithm for acute coronary syndrome is less reliable for patients with known coronary artery disease (CAD). The algorithm’s negative predictive value was below the 99% threshold in this population.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Biomarker Analysis

Background:

  • The European Society of Cardiology (ESC) 0/1-hour algorithm using high-sensitivity cardiac troponin (hs-cTn) is standard for diagnosing acute coronary syndrome (ACS).
  • Limited data exist on its efficacy in patients with pre-existing coronary artery disease (CAD), including prior myocardial infarction (MI) or revascularization.

Purpose of the Study:

  • To evaluate the diagnostic performance of the ESC 0/1-hour algorithm in patients with and without known CAD.
  • To determine if the algorithm can achieve a negative predictive value (NPV) of 99% or higher for 30-day cardiac death or MI in these groups.

Main Methods:

  • A subgroup analysis of the prospective STOP-CP cohort study involving 1430 emergency department patients with ACS symptoms.
  • Patients were stratified using the ESC 0/1-hour high-sensitivity cardiac troponin T (hs-cTnT) algorithm.
  • Outcomes (30-day cardiac death or MI) were adjudicated by experts.

Main Results:

  • The ESC 0/1-hour algorithm classified fewer patients with known CAD (39.6%) into the rule-out zone compared to those without CAD (66.1%).
  • Among rule-out patients, 30-day cardiac death or MI occurred in 3.4% with known CAD versus 1.1% without CAD.
  • The NPV for 30-day cardiac death or MI was 96.6% in patients with known CAD and 98.9% in those without.

Conclusions:

  • The ESC 0/1-hour hs-cTnT algorithm is not sufficiently accurate to rule out 30-day cardiac death or MI in patients with known CAD.
  • Clinicians should exercise caution when applying this algorithm to patients with a history of CAD.
  • The NPV was significantly lower in patients with known CAD, falling below the desired 99% threshold.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
19
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
46
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
216
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
99
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
53
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
31